Early effect of oral administration of omeprazole with mosapride as compared with those of omeprazole alone on the intragastric pH

BMC Gastroenterology

Volumn 12, Issue , 2012, Pages

  Iida, Hiroshi ^a   Inamori, Masahiko ^a,b   Fujii, Tetsuro ^a   Sekino, Yusuke ^a   Endo, Hiroki ^a   Hosono, Kunihiro ^a   Nonaka, Takashi ^a   Koide, Tomoko ^a   Takahashi, Hirokazu ^a   Yoneda, Masato ^a   Goto, Ayumu ^a   Abe, Yasunobu ^a   Kobayashi, Noritoshi ^a   Kirikoshi, Hiroyuki ^a   Kubota, Kensuke ^a   Saito, Satoru ^a   Gotoh, Eiji ^a   Maeda, Shin ^a   Nakajima, Atsushi ^a  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

^b YOKOHAMA CITY UNIVERSITY HOSPITAL   (Japan)

Author keywords

Intragastric acidity; Mosapride; Omeprazole

Indexed keywords

MOSAPRIDE; OMEPRAZOLE; BENZAMIDE DERIVATIVE; GASTROINTESTINAL AGENT; MORPHOLINE DERIVATIVE; PROTON PUMP INHIBITOR;

ABSENCE OF SIDE EFFECTS; ACUTE DRUG ADMINISTRATION; ADULT; ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL EVALUATION; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; GASTRIC PH MONITORING; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; OUTCOME ASSESSMENT; RANDOMIZED CONTROLLED TRIAL; STOMACH ACID SECRETION; STOMACH PH; TREATMENT DURATION; CHEMISTRY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG POTENTIATION; NONPARAMETRIC TEST; PH; SECRETION; STOMACH ACID; STOMACH JUICE;

ADULT; BENZAMIDES; DRUG SYNERGISM; GASTRIC ACID; GASTRIC ACIDITY DETERMINATION; GASTRIC JUICE; GASTROINTESTINAL AGENTS; HUMANS; HYDROGEN-ION CONCENTRATION; MALE; MORPHOLINES; OMEPRAZOLE; PROTON PUMP INHIBITORS; STATISTICS, NONPARAMETRIC; YOUNG ADULT;

EID: 84858739899     PISSN: None     EISSN: 1471230X     Source Type: Journal    
DOI: 10.1186/1471-230X-12-25     Document Type: Article

References (15)

1. Green FW, Kaplan MM, Curtis LE, Levine PH. Effect of acid and pepsin on blood coagulation and platelet aggregation. A possible contributor prolonged gastroduodenal mucosal hemorrhage. Gastroenterology 1978, 74:38-43.
2. Burget DW, Chiverton SG, Hunt RH. Is there an optimal degree of acid suppression for healing of duodenal ulcers? A model of the relationship between ulcer healing and acid suppression. Gastroenterology 1990, 99:345-51.
3. Iida H, Inamori M, Nozaki Y, et al. Early effects of oral administration of lafutidine with mosapride compared with lafutidine alone on intragastric pH values. BMC Gastroenterology 2009, 9:52. 10.1186/1471-230X-9-52, 2714527, 19589146.
4. Yoshikawa T, Yoshida N, Mine Y, et al. Affinity of mosapride citrate, a new gastroprokinetic agent, for 5-HT4 receptors in guinea pig ileum. Jpn J Pharmacol 1998, 77:53-9. 10.1254/jjp.77.53, 9639060.
5. Yoshida N, Ito T, Karasawa T, Itoh Z, et al. AS-4370, a new gastrokinetic agent, enhances upper gastrointestinal motor activity in conscious dogs. J Pharmacol Exp Ther 1991, 257:781-7.
6. Okuno T, Kobayashi H, Haruki S, et al. Pharmacokinetics of FRG-8813 in Rats after Single Oral Dosing. Jpn J Pharmacol 1995, 23:87-104.
7. Wei W, Ge Z-Z, Hong L, et al. Effect of mosapride on gastrointestinal transit time and diagnostic yield of capsule endoscopy. Gastroenterology 2007, 22:1605-1608.
8. Futei S, Sugino Y, Kuribayashi S, et al. New preparation method for barium enema: efficacy and administration of oral intestinal lavage solution with gastrointestinal prokinetic agent. Nippon Igaku Hoshasen 2004, 64:22-30.
9. Oshida N, Omoya H, Oka M, Furukawa K, Ito T, Karasawa T. AS-4370, a novel gastrokinetic agent free of dopamine D2 receptor antagonist properties. Arch Int Pharmacodyn 1989, 300:51-67.
10. Ruth M, Hamelin B, Rohss K, Lundell L. The effect of mosapride, a novel prokinetic, on acid reflux variables in patients with gastro-oesophageal reflux disease. Aliment Pharmacol Ther 1998, 12:35-40. 10.1046/j.1365-2036.1998.00268.x, 9692698.
11. Karamanolis G, Theofanidou I, Yiasemidou M, Giannoulis E, Triantafyllou K, Ladas SD. A glass of water immediately increases gastric pH in healthy subjects. Dig Dis Sci 2008, 53:3128-32. 10.1007/s10620-008-0301-3, 18473176.
12. Inamori M, Togawa J, Iwasaki T, Ozawa Y, Kikuchi T, Muramatsu K, Chiguchi G, Matsumoto S, Kawamura H, Abe Y, Kirikoshi H, Kobayashi N, Shimamura T, Kubota K, Sakaguchi T, Saito S, Ueno N, Nakajima A. Early effects of lafutidine or rabeprazole on intragastric acidity: which drug is more suitable for on-demand use?. J Gastroenterol 2005, 40:453-8. 10.1007/s00535-005-1569-0, 15942709.
13. Abe Y, Inamori M, Togawa J, et al. The comparative effects of single intravenous doses of omeprazole and famotidine on intragastric pH. J Gastroenterol 2004, 39:21-5. 10.1007/s00535-003-1240-6, 14767730.
14. Inamori M, Togawa J, Chiguchi G, et al. The Evaluation of Anti-secretory Drugs on Intragastric Acidity; Are the Combined Therapy of a Proton Pump Inhibitor and a H2 Receptor Antagonist Effective as an Initial Treatment?. J Gastroenterol 2005, 40:213-4. 10.1007/s00535-004-1521-8, 15770408.
15. Inamori M, Akimoto K, Akiyama T, et al. Is Oral Combination Therapy with a Proton Pump Inhibitor and H2 Receptor Antagonist Effective as Initial Treatment?. J Gastroenterol 2007, 42:510-1. 10.1007/s00535-007-2024-1, 17671771.